Gefitinib (IRESSA) versus docetaxel in patients with locally advanced or metastatic non-small-cell lung cancer pre-treated with platinum-based chemotherapy: a randomized, open-label Phase III study (INTEREST)

被引：60

作者：

Douillard, Jean-Yves

Kim, Edward

Hirsh, Vera

Mok, Tony

Socinski, Mark

Gervais, Radj

Wu, Yi-Long

Li, Longyun

Sellers, Mark

Lowe, Elizabeth

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX H2W 1S4 USA

[2] Med Oncol Ctr R Gauducheu, St Herblain, France

[3] McGill Univ, Hlth Ctr, Montreal, PQ, Canada

[4] Chinese Univ Hong Kong, Sch Publ Hlth, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China

[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[6] Ctr Reg Lutte Contre Canc Baclesse, Caen, France

[7] Guang Dong Provincial People Hosp, Guangzhou, Peoples R China

[8] Beijing Union Med Coll Hosp, Beijing, Peoples R China

[9] AstraZeneca, Macclesfield, Cheshire, England

[10] Astrazeneca, Wilmington, DE USA

来源：

关键词：

D O I：

10.1097/01.JTO.0000283087.71346.19

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S305 / S306

页数：2